Cosimo Prantera

6.4k total citations · 1 hit paper
82 papers, 4.3k citations indexed

About

Cosimo Prantera is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Cosimo Prantera has authored 82 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Genetics, 53 papers in Epidemiology and 36 papers in Surgery. Recurrent topics in Cosimo Prantera's work include Inflammatory Bowel Disease (66 papers), Microscopic Colitis (43 papers) and Eosinophilic Esophagitis (11 papers). Cosimo Prantera is often cited by papers focused on Inflammatory Bowel Disease (66 papers), Microscopic Colitis (43 papers) and Eosinophilic Esophagitis (11 papers). Cosimo Prantera collaborates with scholars based in Italy, Netherlands and United States. Cosimo Prantera's co-authors include Maria Lia Scribano, C Luzi, Arnaldo Andreoli, Eva Berto, Vilma Varvo, S. Levenstein, Mario Cottone, Anna Kohn, Massimo Campieri and Francesco Pallone and has published in prestigious journals such as Gastroenterology, Gut and Cochrane Database of Systematic Reviews.

In The Last Decade

Cosimo Prantera

80 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of the perceived stress questionnaire: A new tool for psychosomatic research

1993 747 citations S. Levenstein, Cosimo Prantera et al. profile →

Peers

Countries citing papers authored by Cosimo Prantera

Since Specialization

Citations

This map shows the geographic impact of Cosimo Prantera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cosimo Prantera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cosimo Prantera more than expected).

Fields of papers citing papers by Cosimo Prantera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cosimo Prantera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cosimo Prantera. The network helps show where Cosimo Prantera may publish in the future.

Co-authorship network of co-authors of Cosimo Prantera

This figure shows the co-authorship network connecting the top 25 collaborators of Cosimo Prantera. A scholar is included among the top collaborators of Cosimo Prantera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cosimo Prantera. Cosimo Prantera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease 2011 ·Gastroenterology ·Cosimo Prantera, Herbert Lochs, Maria Grimaldi, Silvio Danese, Maria Lia Scribano, Paolo Gionchetti	138
2	Antibiotics and probiotics in inflammatory bowel disease: why, when, and how 2009 ·Current Opinion in Gastroenterology ·Cosimo Prantera, Maria Lia Scribano	34
3	What role do antibiotics have in the treatment of IBD? 2008 ·Nature Clinical Practice Gastroenterology &#38 Hepatology ·Cosimo Prantera	12
4	Mycobacteria and Crohn's disease: The endless story 2007 ·Digestive and Liver Disease ·Cosimo Prantera	9
5	A New Oral Delivery System for 5-ASA: Preliminary Clinical Findings for MMX 2005 ·Inflammatory Bowel Diseases ·Cosimo Prantera, Angelo Viscido, Livia Biancone, A. Francavilla, (unknown), Massimo Campieri	118
6	Medical treatment of moderate to severe Crohn's disease 2003 ·Alimentary Pharmacology & Therapeutics ·Maria Lia Scribano, Cosimo Prantera	12
7	Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial 2002 ·Digestive and Liver Disease ·P. Paoluzi, G d'Albasio, A. Pera, G. Bianchi Porro, Omero Alessandro Paoluzi, Roberta Pica, Mario Cottone, M. Miglioli, Cosimo Prantera, Giacomo Carlo Sturniolo, Sandro Ardizzone	32
8	Probiotics and Crohn's disease 2002 ·Digestive and Liver Disease ·Cosimo Prantera, Maria Lia Scribano	26
9	Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG 2002 ·Gut ·Cosimo Prantera	388
10	Use of anti-tumour necrosis factor agents in inflammatory bowel disease 2001 ·International Journal of Colorectal Disease ·Stefan Schreiber, Massimo Campieri, Jean‐Frédéric Colombel, Sander J. H. van Deventer, Brian Feagan, Richard N. Fedorak, Alastair Forbes, M.À. Gassull, Gendre Jp, R. A. van Hogezand, Robert Löfberg, R Modigliani, Francesco Pallone, Wolfgang Petritsch, Cosimo Prantera, David S. Rampton, Frank Seibold, Morten Vatn, Martin Zeitz, P. Rutgeerts	36
11	Stress and Exacerbation in Ulcerative Colitis: A Prospective Study of Patients Enrolled in Remission 2000 ·The American Journal of Gastroenterology ·Susan Levenstein, Cosimo Prantera, Vilma Varvo, Maria Lia Scribano, Arnaldo Andreoli, C Luzi, Massimo Arcà, Eva Berto, Giustina Milite, Adriana Marcheggiano	343
12	Prospective Evaluation of Transabdominal Bowel Sonography in the Diagnosis of Intestinal Obstruction in Crohnʼs Disease: Comparison with Plain Abdominal Film and Small Bowel Enteroclysis 1999 ·Inflammatory Bowel Diseases ·Anna Kohn, P Cerro, Giustina Milite, (unknown), Cosimo Prantera	54
13	Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 1999 ·Gastroenterology ·Cosimo Prantera, Mario Cottone, Francesco Pallone, Vito Annese, A. Franzè, Renata Cerutti, Gabriele Bianchi Porro	80
14	Maintenance Treatment of Ulcerative Proctitis With Mesalazine Suppositories: A Double-Blind Placebo-Controlled Trial 1998 ·The American Journal of Gastroenterology ·G d'Albasio, Omero Alessandro Paoluzi, Massimo Campieri, (unknown), A. Pera, Cosimo Prantera, G.C. Sturniolo, M. Miglioli	45
15	Role of Ultrasonography in the Diagnosis of Postsurgical Recurrence of Crohn's Disease 1998 ·The American Journal of Gastroenterology ·Arnaldo Andreoli, P Cerro, (unknown), (unknown), Cosimo Prantera	60
16	Metronidazole Plus Ciprofloxacin in the Treatment of Active, Refractory Crohn???s Disease: Results of an Open Study 1994 ·Journal of Clinical Gastroenterology ·Cosimo Prantera, Anna Kohn, F. Zannoni, (unknown), (unknown)	32
17	Life Events, Personality, and Physical Risk Factors in Recent-Onset Duodenal Ulcer 1992 ·Journal of Clinical Gastroenterology ·Susan Levenstein, Cosimo Prantera, Vilma Varvo, (unknown), Massimo Arcà, (unknown)	11
18	Analysis of clinical course of postoperative recurrence in Crohn's Disease of distal ileum 1992 ·Digestive Diseases and Sciences ·Francesco Pallone, Monica Boirivant, Maria Antonietta Stazi, R. Cosintino, Cosimo Prantera, A Torsoli	49
19	Clinical and Laboratory Indicators of Extent of Ulcerative Colitis 1988 ·Journal of Clinical Gastroenterology ·Cosimo Prantera, Marina Davoli, Roberto Lorenzetti, Francesco Pallone, Adriana Marcheggiano, C. Iannoni, Sergio Mariotti	48
20	Prediction of surgery for obstruction in Crohn's ileitis 1987 ·Digestive Diseases and Sciences ·Cosimo Prantera, S. Levenstein, Riccardo Capocaccia, Sergio Mariotti, C Luzi, R. Cosintino, M Simi	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact